These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 38349409)
1. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers. Ebrahimi R; Nasri F; Kalantari T Ann Hematol; 2024 Jun; 103(6):1819-1831. PubMed ID: 38349409 [TBL] [Abstract][Full Text] [Related]
2. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thålin C; Phillipson M Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):988-994. PubMed ID: 33267662 [TBL] [Abstract][Full Text] [Related]
3. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy. Khezri MR; Varzandeh R; Ghasemnejad-Berenji M Cell Mol Biol Lett; 2022 Jan; 27(1):6. PubMed ID: 35016612 [TBL] [Abstract][Full Text] [Related]
4. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651 [TBL] [Abstract][Full Text] [Related]
5. Major coagulation disorders and parameters in COVID-19 patients. Teimury A; Khameneh MT; Khaledi EM Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674 [TBL] [Abstract][Full Text] [Related]
6. The most important biomarker associated with coagulation and inflammation among COVID-19 patients. Hong LZ; Shou ZX; Zheng DM; Jin X Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367 [TBL] [Abstract][Full Text] [Related]
7. Haematological manifestations of COVID-19: From cytopenia to coagulopathy. Agbuduwe C; Basu S Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356 [TBL] [Abstract][Full Text] [Related]
8. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193 [TBL] [Abstract][Full Text] [Related]
9. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Mackman N; Antoniak S; Wolberg AS; Kasthuri R; Key NS Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2033-2044. PubMed ID: 32657623 [TBL] [Abstract][Full Text] [Related]
10. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. Yamada S; Asakura H Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761 [TBL] [Abstract][Full Text] [Related]
11. Complement activation and coagulopathy - an ominous duo in COVID19. Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807 [TBL] [Abstract][Full Text] [Related]
13. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Lazzaroni MG; Piantoni S; Masneri S; Garrafa E; Martini G; Tincani A; Andreoli L; Franceschini F Blood Rev; 2021 Mar; 46():100745. PubMed ID: 32868115 [TBL] [Abstract][Full Text] [Related]
14. Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes. Zadow EK; Wundersitz DWT; Hughes DL; Adams MJ; Kingsley MIC; Blacklock HA; Wu SSX; Benson AC; Dutheil F; Gordon BA Semin Thromb Hemost; 2020 Oct; 46(7):807-814. PubMed ID: 32882720 [TBL] [Abstract][Full Text] [Related]
15. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study. Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475 [TBL] [Abstract][Full Text] [Related]
16. [Peculiarities of blood coagulation disorders in patients with COVID-19]. Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646 [TBL] [Abstract][Full Text] [Related]
17. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy. Kinaneh S; Khamaysi I; Karram T; Hamoud S Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790 [TBL] [Abstract][Full Text] [Related]
18. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases. Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334 [TBL] [Abstract][Full Text] [Related]
19. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Fletcher-Sandersjöö A; Bellander BM Thromb Res; 2020 Oct; 194():36-41. PubMed ID: 32569879 [TBL] [Abstract][Full Text] [Related]
20. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA. Henry BM; Szergyuk I; de Oliveira MHS; Abosamak MF; Benoit SW; Benoit JL; Lippi G Diabetes Metab Syndr; 2021; 15(3):863-868. PubMed ID: 33878674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]